SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. SU5416 may stop the growth of solid tumors by stopping blood flow
to the tumor. Combining SU5416 with chemotherapy may kill more cancer cells.
PURPOSE: Phase I trial to study the effectiveness of SU5416 plus irinotecan and cisplatin in
treating patients who have advanced solid tumors.